A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei

被引：38

作者：

Waag, DM

McCluskie, MJ

Zhang, NL

Krieg, AM

机构：

[1] USA, Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA

[2] Coley Pharmaceut Grp, Wellesley, MA USA

[3] Coley Pharmaceut Grp, Ottawa, ON, Canada

来源：

INFECTION AND IMMUNITY | 2006年 / 74卷 / 03期

关键词：

D O I：

10.1128/IAI.74.3.1944-1948.2006

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Treatment with an oligodeoxynucleotide (ODN) containing CPG motifs (CpG ODN 7909) was found to protect BALB/c mice from lung infection or death after aerosol challenge with Burkholderia mallei. Protection was associated with enhanced levels of gamma interferon (IFN-gamma)-inducible protein 10, interleukin-12 (IL-12), IFN-gamma, and IL-6. Preexposure therapy with CpG ODNs may protect victims of a biological attack from glanders.

引用

收藏

页码：1944 / 1948

页数：5

相关论文

共 25 条

[1] Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].

Bauer, S ;

Kirschning, CJ ;

Häcker, H ;

Redecke, V ;

Hausmann, S ;

Akira, S ;

Wagner, H ;

Lipford, GB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242

[2]

Elkins KL, 1999, J IMMUNOL, V162, P2291

[3] Interleukin-12-and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice [J].

Gramzinski, RA ;

Doolan, DL ;

Sedegah, M ;

Davis, HL ;

Krieg, AM ;

Hoffman, SL .

INFECTION AND IMMUNITY, 2001, 69 (03) :1643-1649

[4] Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides [J].

Hornung, V ;

Rothenfusser, S ;

Britsch, S ;

Krug, A ;

Jahrsdörfer, B ;

Giese, T ;

Endres, S ;

Hartmann, G .

JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4531-4537

[5] Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection [J].

Klinman, DM ;

Conover, J ;

Coban, C .

INFECTION AND IMMUNITY, 1999, 67 (11) :5658-5663

[6] Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-Class CpG oligodeoxynucleotide TLR9 agonist [J].

Krieg, AM ;

Efler, SM ;

Wittpoth, M ;

Al Adhami, MJ ;

Davis, HL .

JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) :460-471

[7] CpG motifs in bacterial DNA and their immune effects [J].

Krieg, AM .

ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :709-760

[8]

Krieg AM, 1998, J IMMUNOL, V161, P2428

[9]

Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO

[10]

2-U